Results 161 to 170 of about 10,367,890 (306)

Unique circulating miRNAome signatures captured with distinct molecular states in Lynch syndrome and sporadic colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Circulating microRNA profiles distinguish nonmalignant Lynch syndrome from cancer‐associated Lynch syndrome, sporadic colorectal cancer, and healthy controls. Age‐stratified analysis reveals disease‐specific regulatory states, and a six‐miRNA panel shows concordant separation in an independent colorectal tissue cohort.
Ramadhani Salum Chambuso   +5 more
wiley   +1 more source

Nanocomposites of Poly(n-Butyl Acrylate) with Fe3O4: Crosslinking with Hindered Urea Bonds, Reprocessing and Related Functional Properties

open access: yes
In this contribution, we reported the synthesis of the nanocomposites of poly(n-butyl acrylate) with Fe3O4 nanoparticles (NPs) via dynamic crosslinking of poly(n-butyl acrylate)-grafted Fe3O4 NPs with hindered urea bonds (HUBs).
Huaming Wang   +6 more
core   +1 more source

Editorial: Developing medicinal plant extracts commercially: The importance of extraction and fractionation

open access: yesFrontiers in Pharmacology, 2023
Thomas Brendler   +5 more
doaj   +1 more source

SPHINX31 acts as a SRPK1 inhibitor targeting the ATR/DNA‐PKcs/CHK1 replicative checkpoint to inhibit cell growth in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
The kinase SRPK1 directly interacts with the protein TOPBP1 and regulates the pre‐mRNA splicing of WIZ thereby contributing to the activation of the ATR/CHK1 replicative checkpoint in response to replicative stress. This allows cancer cells' genomic stability and survival.
Amani Shreim   +17 more
wiley   +1 more source

Monotonic properties of the Green’s function [PDF]

open access: yesProceedings of the American Mathematical Society, 1952
Miller, Kenneth S., Schiffer, Menahem M.
openaire   +2 more sources

Mutant p53R273H disrupts PDPK1 homodimerization and contributes to PDPK1 activation

open access: yesMolecular Oncology, EarlyView.
How mutant p53R273H drives AKT signaling is unclear. We show that p53R273H, but not wild‐type, directly binds PDPK1 via a mutation‐dependent conformational change. This interaction disrupts inhibitory PDPK1 homodimerization and enhances AKT phosphorylation.
Mei Chee Lim   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy